Tag: clinical mass spectrometry market analysis
Agilent Technologies has announced it has launched two new mass spectrometry devices catering to the clinical mass spectrometry market
Clinical mass spectrometry has ease measuring and distinguishing of separate contributions of molecules such as thyroid hormones and 25-hydroxyl vitamins D2 and D3. This advantage of such a device is expected to drive the growth of the clinical mass spect...
0
0
0
20 Aug, 12:32 PM